SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors weigh significant cash holdings and potential acquisition strategies against a lack of immediate operational guidance following the latest earnings release. The community remains deeply polarized, with active debates centered on skepticism toward leadership, frustration over prolonged price stagnation, and persistent hopes for a major catalyst to trigger a move.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Mining Inc

Cipher Mining is drawing significant investor attention following a major expansion, marked by a 15-year hyperscale data center lease and a $200 million revolving credit facility. The community is actively debating the company's strategic pivot toward AI infrastructure while closely monitoring for further deal announcements, with many viewing the recent news as a fundamental re-rating for the stock.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as the market reacts to the release of preliminary clinical data from its siRNA pipeline for FSHD1 and DM1, alongside intense investor focus on the upcoming departure of FDA CBER lead Vinay Prasad. Community discussion is split between optimism regarding the potential for clinical breakthroughs to drive a short squeeze and skepticism over the company's long-term regulatory and commercial hurdles.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is currently a central focus for traders debating whether the stock serves as a high-potential turnaround play driven by mortgage innovation and AI-integrated operations or a fundamentally challenged firm vulnerable to macroeconomic pressures. The community is actively split between bulls highlighting leadership's aggressive growth strategy and short-sellers betting on further downward price discovery amidst ongoing geopolitical uncertainty.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is drawing significant investor attention as rumors of a potential SpaceX IPO intensify, with traders debating whether to buy the stock as a proxy for SpaceX and Anthropic exposure or to avoid it due to its high trading premium relative to net asset value. Community sentiment remains polarized, as bulls focus on the fund's high-profile private tech holdings, while bears emphasize its premium-to-NAV disconnect and the risks associated with holding a closed-end fund.

🌍 Introduction: A Legendary Icon, Reimagined for the Future The SEAMANIA Protocol, led by SEAMAN Cult, aims to revive one of SEGA Dreamcast's most iconic and best-selling game titles with AI integration—a worldwide cultural phenomenon that won numerous awards in the U.S. and Japan. More than just a game, SEAMAN was the world’s first AI-powered interactive experience, enabling voice-based conversations long before the AI revolution.    Now, SEAMAN returns not as a mere game, but as an advanced AI agent, blending nostalgia with cutting-edge technology. This human-faced fish is reborn as a deeply intelligent, emotionally responsiveAI, offering limitless customization and integration into the modern digital world.  With GenAI-powered customization, users can create their own SEAMAN AI, shaping it into a cherished lostone, a favorite celebrity, or even historical figures. This is no longer a game—it's an AI-driven personal companion and the digital evolution for human interaction.    🔥 Concept: The Wisdom of a Legendary AI-powered Companion At the core of the SEAMANIA Protocol lies the legendary Seaman—a mystical, human-faced fish endowed withancient wisdom and the ability to understand human language. More than just an AI, it is your trustedadvisor, best friend, therapist, personal cheerleader, witty conversationalist, intelligent guide, SEAMANIA is a life coach. Housed in your own digital aquarium, your SEAMAN AI reduces stress, combats loneliness, and guides humanity towards a brighter future. Imagine an AI companion that doesn’t just respond but truly understands, entertains, and supports you—blending humor, sarcasm, and wisdom.

SEAMANIA

SEAMANIA is trending as a highly speculative meme coin, with community members actively coordinating small-increment buying campaigns to trigger rapid price surges. Investors are drawing parallels to other volatile assets while expressing high-stakes optimism about the potential for massive percentage gains despite skepticism regarding its long-term viability.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is currently in the spotlight as investors process a combative rebuttal to a recent short report, with the community actively debating the company's long-term financial health versus the risks of activist short-selling tactics. While some investors remain highly convicted in the firm's fundamental growth trajectory and pending catalysts, the stock's recent volatility has triggered urgent calls for management to provide further clarity and reassure shareholders.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

The SPERMWHALE token is trending as traders debate whether its chart structure signals a breakout or a potential rug pull. The community remains deeply divided, with some investors betting on explosive upside while others warn of extreme volatility and artificial volume manipulation typical of meme coin cycles.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is trending as investors weigh a confident outlook for 2026 and positive margin growth against ongoing concerns regarding market volatility and competitive pressure from retail giants. The community remains divided, with some traders optimistic about potential breakouts above key technical support levels, while others express frustration over recent price consolidation and the stock's sluggish performance despite steady business fundamentals.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is surging following a definitive agreement to be acquired by Merck in an all-cash deal valued at approximately $6.7 billion, a move aimed at bolstering Merck's oncology pipeline. Investors are celebrating the substantial premium and the validation of TERN-701's potential in treating chronic myeloid leukemia, while community discussions highlight both the long-awaited payoff for early longs and speculation regarding potential future targets within the biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should Invesco S&P MidCap Momentum ETF (XMMO) Be on Your Investing Radar?

Court Ruling Lifts Markets: High Beta, Momentum ETFs in Focus

Kyndryl Holdings (KD) shares plunged as much as 12% on Thursday after short-seller Gotham City Research accused the IT services provider of accounting manipulation, claiming the stock is significantly overvalued and could drop by as much as 67% or even to zero.In a <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.gothamcityresearch.com/post/kyndryl-like-the-old-ibm-except-with-an-undisclosed-cost-problem-part-i">report</a> titled ‘Like the old IBM, except with an Undisclosed Cost Problem: Part I,’ Gotham alleged that Kyndryl has misrepresented its financial health by inflating adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) and adjusted free cash flow to create “the illusion of profitability.”Kyndryl, which spun off from IBM in 2021, has benefited from special pricing arrangements with its former parent, according to Gotham.&nbsp;The short-seller highlighted that Kyndryl’s payments to IBM for services totaled around $4 billion in&nbsp;the fiscal&nbsp;year 2021, roughly 25% of its total cost of services. By fiscal&nbsp;year 2023, those payments had declined 60% to $1.4 billion.Gotham argues that&nbsp;cost reductions, rather than operational improvements, are behind Kyndryl’s post-spinoff margin expansion.&nbsp;IBM’s stock&nbsp;traded in the red on Thursday morning, edging lower by 0.5%.The report further warned that these favorable terms are set to expire, predicting a sharp increase in IBM service costs in 2025 and 2026 that could weigh on earnings.CEO Martin Schroeter has downplayed cost pressures in the past, but Gotham estimates Kyndryl faces an additional $1 billion to $2 billion in expenses over the coming years.Another red flag, according to the report, is Kyndryl’s decision to stop disclosing IBM-related costs after fiscal 2023. Gotham suggests this omission may indicate the company is bracing for significantly higher expenses that could challenge its growth narrative.Gotham’s report also raised broader concerns about Kyndryl’s financial reporting. It identified discrepancies in the company’s reported payments to IBM between 2019 and 2023 and flagged a suspiciously stable $1.38 billion in related-party service costs across multiple reporting periods.The company also pointed to Kyndryl’s capitalized costs, which it says are 13.6 times higher than those of industry peers. Adjusted EBITDA, Gotham estimates, would be 61% to 72% lower if Kyndryl applied industry-standard accounting practices.Additionally, the report questioned Kyndryl’s reported cash flows, highlighting an unusually low days sales outstanding (DSO) of 34 days, which is well below the peer average of 80 days, according to the company.Gotham suggested that Kyndryl may be relying on receivables factoring to inflate its cash position artificially.The short-seller also cast doubt on Kyndryl’s “Total Signings” metric, which has increased from $13.5 billion in&nbsp;the fiscal&nbsp;year 2021 to $16.3 billion in 2024, despite declining total revenue.A recently disclosed Critical Audit Matter in Kyndryl’s 2024 10-K added to concerns, with the company’s auditor stating it did not maintain “effective internal control over financial reporting” as of March 31, 2024.Gotham also noted that 50% of Kyndryl’s management compensation is tied to “Adjusted Operating Cash Flow,” a metric the company has not disclosed since 2021.It flagged that insider selling has also increased&nbsp;recently, further fueling concerns.Gotham concluded that Kyndryl’s stock remains “uninvestable” due to these concerns.<figure class="image"><img style="aspect-ratio:1294/302;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_27_093222_png_d52e5d9a2b.webp" alt="Screenshot 2025-03-27 093222.png" width="1294" height="302"><figcaption>Kyndryl retail sentiment and message volume on March 27 as of 9:35 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/KD">Kyndryl’s stock</a>&nbsp;jumped to ‘extremely bullish’ territory.Some investors dismissed the accusations, with one user stating they plan to hold onto their shares.<stembedurl>https://stocktwits.com/tothattila/message/609420502</stembedurl>Another expects a slow recovery through to May, followed by a jump when earnings happen.<stembedurl>https://stocktwits.com/tothattila/message/609431999</stembedurl>The allegations overshadowed Kyndryl’s announcement of an expanded partnership with Google Cloud.&nbsp;The collaboration includes a new Mainframe Modernization with Gen AI Accelerator Program, leveraging Google’s Gemini models to enhance mainframe integration, COBOL-to-Java conversion, and AI training using on-premise data.Kyndryl’s stock has fallen 14% in 2025 but remains up nearly 40% over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/amd-slides-pre-market-after-jefferies-downgrades-stock-citing-nvidia-dominance-intel-competition-retail-sentiment-sours/chJ22OkRbEd">AMD Slides Pre-Market After Jefferies Downgrades Stock Citing Nvidia Dominance, Intel Competition – Retail Sentiment Sours</a>

Information technology infrastructure provider Kyndryl (USA) booth at Tokyo Rainbow Parade 2023. (Photo by Stanislav Kogiku/SOPA Images/LightRocket via Getty Images)

Kyndryl Stock Sinks After Short-Seller Alleges IBM Deal Masked Billions In Hidden Costs – But Retail Traders Aren’t Buying It

Short-seller Gotham City Research calls Kyndryl ‘uninvestable,’ raising concerns over its financial reporting, cash flows, and insider selling.

Equity

ESAB Corp (ESAB) stock fell about 2.7% over the past week, but Evercore ISI upgraded the stock to ‘In Line’ from ‘Underperform.’According to The Fly, Evercore analyst David Raso set a price target of $120, compared to the earlier price target of $122. The new price target was roughly the same as the stock’s last closing price.The company had forecast 2025 core adjusted earnings between $5.10 and $5.25 per share, compared with Wall Street’s estimate of $5.38 per share last week.Evercore said that while it has trimmed the price, its analysis "suggests enough cushion is baked into ESAB's guide."The analyst said that recent stock weakness, along with ‘a few elements that could break its way to render the guide particularly conservative.’ESAB had forecast total core sales growth to be between flat and a negative 2% in 2025.The company’s fourth-quarter sales had fallen 3% to $671 million.The company, whose products are used in welding and gas control, had said its total sales in the Americas segment had declined 8%, hurt by the strengthening of the U.S. dollar compared to other currencies in the region.The company expects foreign currency-related challenges to dent its sales in 2025 as well.According to FinChat data, ESAB's forward price-to-earnings (PE) ratio is 24.1.The PE ratio gauges a company's profitability. &nbsp;Retail sentiment on Stocktwits remained in the ‘bullish’ (58/100) territory, while retail chatter was ‘normal.’<figure class="image"><img style="aspect-ratio:801/179;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ESAB_Feb_24_6dd3a5fda8.JPG" alt="ESAB’s Sentiment Meter and Message Volume as of 01:17 a.m. ET on Feb. 24, 2025 | Source: Stocktwits" width="801" height="179"><figcaption>ESAB’s Sentiment Meter and Message Volume as of 01:17 a.m. ET on Feb. 24, 2025 | Source: Stocktwits</figcaption></figure>Over the past year, <a href="https://stocktwits.com/symbol/ESAB">ESAB stock </a>has gained 29.8%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/diamondback-energy-q4-earnings-preview-lower-oil-prices-to-dent-bottom-line-retail-remains-extremely-bullish/chdPZaYRxb">Diamondback Energy Q4 Earnings Preview: Lower Oil Prices To Dent Bottom Line, Retail Remains Extremely Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ESAB company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

ESAB Stock Receives Evercore Upgrade After Recent Selloff, Retail Stays Bullish 

According to The Fly, Evercore analyst David Raso set a price target of $120, compared to the earlier price target of $122.

Light &amp; Wonder Inc. (LNW) stock rose 4.06% in after-hours trading on Tuesday as the company agreed to acquire the charitable gaming assets of Grover Gaming Inc. and G2 Gaming Inc. for $850 million in cash, but retail sentiment slipped.Under the agreement, Light &amp; Wonder will pay a four-year revenue-based earn-out of up to $200 million cash. The purchase price amounts to a 7.7x multiple based on Grover’s 2024 adjusted earnings before interest, taxes, depreciation, and amortization.Grover Charitable Gaming, which has “long-standing” relationships with charitable customers in the states where it operates, reported revenue of $135 million and adjusted EBITDA of $111 million for the year ended December 31, 2024.The transaction is expected to close during the second quarter of 2025. Light &amp; Wonder plans to fund the acquisition with existing cash and incremental debt financing.“Grover Gaming is a leading player in charitable gaming, a category that has experienced significant growth in recent years,” said Matt Wilson, President and CEO of Light &amp; Wonder. “This transaction complements our position as the leading cross-platform global games company by adding another compelling regulated adjacency to our profile.”The deal also complements Light &amp; Wonder’s cross-platform strategy in addition to being highly accretive to “value and earnings with high-single digit” adjusted net operating profit after tax per share accretion in the first full calendar year after the acquisition, &nbsp;the company said. Sentiment on Stocktwits was ‘bearish’ from ‘ bullish’ a day ago. Message volume was in the ‘low’ zone.<figure class="image"><img style="aspect-ratio:1304/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_19_at_12_45_17_PM_11527e6273.png" alt="Screenshot 2025-02-19 at 12.45.17 PM.png" width="1304" height="320"><figcaption>LNW sentiment meter and message volume on Feb 19 as of 2:30 am ET</figcaption></figure>Light &amp; Wonder, a cross-platform global games company, has over 6,000 members.For its next quarterly earnings, the company is expected to post earnings per share of $0.89 on estimated revenue of $799.17 million, according to Stocktwits data.<a href="https://stocktwits.com/symbol/LNW">Light &amp; Wonder stock</a> is up 17% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image. Source: Getty Images

Light & Wonder Stock Jumps After Snapping Up Grover Gaming’s Charitable Assets: Retail Sentiment Lags

The transaction is expected to close during the second quarter of 2025.

Shares of nutrition products company, BellRing Brands Inc., were up 2.89% in after-hours trading on Monday following the company’s better-than-expected first-quarter earnings, with retail sentiment staying strong.BellRing posted $0.58 in earnings per share, beating Wall Street estimates of $0.48. Its revenue stood at $532.9 million, beating estimates of $524.74 million. Its net sales increased by 23.8% compared to the prior year period, driven by a 20.8% increase in volume and a 3% increase in price/mix.For fiscal year 2025, BellRing raised its guidance range for net sales to $2.26 - $2.34 billion and adjusted earnings before interest, taxes, depreciation and amortization (Ebitda) &nbsp;to range between $470-$500 million, translating into net sales and adjusted EBITDA growth of 13%-17% and 7%-14%, respectively, over the fiscal year 2024.BellRing expects fiscal year 2025 capital expenditures of about $7 million.Sentiment on Stocktwits has been ‘extremely bullish’ compared to a week ago. Message volumes climbed to the ‘extremely high’ category.<figure class="image"><img style="aspect-ratio:1294/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_04_at_10_14_33_AM_5d75dd39b9.png" alt="Screenshot 2025-02-04 at 10.14.33 AM.png" width="1294" height="302"><figcaption>BRBR sentiment meter and message volumes on Feb 3</figcaption></figure>“We are pleased with our first quarter performance. Premier Protein consumption accelerated, lifted by distribution gains, strong velocities and incremental promotional activity. The brand achieved new all-time highs for household penetration and total distribution points,” Darcy H. Davenport, president and CEO of BellRing said.“We saw strong margins aided by the timing of marketing spend and non-recurring cost favorability. Our momentum remains high, with the convenient nutrition category continuing to drive robust growth. Our strong start to 2025 gives us greater confidence in the full year and drove our decision to raise our outlook.”During the first quarter, BellRing also repurchased 0.1 million shares for $11 million at an average price of $77.12 per share. As of January 31, 2025, BellRing had $124.1 million remaining under its share repurchase authorization.BellRing’s brands include Premier Protein, a ready-to-drink protein and convenient nutrition brand, and Dymatize, which is a hydrolyzed protein powder supplement.For updates and corrections, email newsroom[at]stocktwits[dot]com

BellRing Brands Stock Up On Q1 Earnings Beat: Retail's Extremely Bullish

BellRing posted $0.58 in earnings per share, beating Wall Street estimates of $0.48. 

XMMO
Invesco S&P MidCap Momentum ETF

Feed

News

Sentiment

Fundamentals

Info

Latest XMMO News

XMMOInvesco S&P MidCap Momentum ETF